OneStream, Inc.(OS)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OS OneStream, Inc.

盘前交易 12-15 07:55:08 EST

17.74

-0.32

-1.77%

盘前17.95

+0.21+1.18%

06:52 EST

最高18.18	最低17.51	成交量90.63万
今开18.07	昨收18.06	日振幅3.71%
总市值43.46亿	流通市值39.15亿	总股本2.45亿
成交额1,611万	换手率0.41%	流通股本2.21亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"OS","market":"US","secType":"STK","nameCN":"OneStream, Inc.","latestPrice":17.74,"timestamp":1765573200000,"preClose":18.06,"halted":0,"volume":906326,"hourTrading":{"tag":"盘前","latestPrice":17.95,"preClose":17.74,"latestTime":"06:52 EST","volume":53,"amount":951.010058,"timestamp":1765799526289},"delay":0,"floatShares":220698554,"shares":244977000,"eps":-0.97803,"marketStatus":"盘前交易","change":-0.32,"latestTime":"12-15 07:55:08 EST","open":18.065,"high":18.18,"low":17.51,"amount":16109509.613519998,"amplitude":0.037099,"askPrice":19.48,"askSize":100,"bidPrice":16.23,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.97803,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765809000000},"marketStatusCode":1,"adr":0,"listingDate":1721793600000,"exchange":"NASDAQ","adjPreClose":17.74,"preHourTrading":{"tag":"盘前","latestPrice":17.95,"preClose":17.74,"latestTime":"06:52 EST","volume":53,"amount":951.010058,"timestamp":1765799526289},"postHourTrading":{"tag":"盘后","latestPrice":17.87,"preClose":17.74,"latestTime":"18:51 EST","volume":17224,"amount":305657.04,"timestamp":1765583490774},"volumeRatio":0.6026289934675048,"impliedVol":0.5805,"impliedVolPercentile":0.3936},"requestUrl":"/m/hq/s/OS/tweets","defaultTab":"tweets","newsList":[{"id":"2590378406","title":"尘封28年CHRP版Mac OS 7.6光盘泄露","url":"https://stock-news.laohu8.com/highlight/detail?id=2590378406","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590378406?lang=zh_cn&edition=full","pubTime":"2025-12-10 08:05","pubTimestamp":1765325102,"startTime":"0","endTime":"0","summary":"科技媒体 The Register 报道，软件存档网站 Macintosh Garden 近日获得三张刻录于1997年5月至9月的 CD-R 光盘，内含从未发布的 CHRP 版 Mac OS 7.6 与 Mac OS 8 系统。CHRP 全称为“通用硬件参考平台”，是苹果与 IBM 联合开发的行业标准，旨在建立统一的 PowerPC 硬件基础，使 macOS 可运行于非苹果品牌的兼容机上。然而，随着1997年史蒂夫乔布斯回归苹果并终止 Mac 克隆机项目，公司转向收紧硬件控制权，导致 CHRP 版 Mac OS 因失去应用场景而被废弃。有用户在 MacOS9Lives 论坛表示，已成功于 Mac mini G4 设备上启动该系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210080641a43ea335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210080641a43ea335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2461242641.AUD","LU2756315318.SGD","LU1699723380.USD","HK0000320264.USD","LU2430703095.HKD","SG9999014575.USD","IE0005OL40V9.USD","BK4505","LU1823568750.SGD","LU0784385170.HKD","LU0353189763.USD","IE0009G5SDU7.USD","LU0203201768.USD","SG9999015978.USD","LU0203202063.USD","LU1868836757.USD","SG9999017495.SGD","LU1116320737.USD","BK4507","LU2237443978.SGD","IE0003U64NQ7.SGD","LU2456880835.USD","LU0528227936.USD","LU0345770308.USD","LU2250418816.HKD","LU0640476718.USD","LU0345768153.USD","LU2106854487.HKD","LU0472753341.HKD","LU0238689110.USD","LU2347655073.USD","LU0354030511.USD","LU2452424414.USD","LU0157215616.USD","LU2471134952.CNY","LU1066051225.USD","LU2065171402.SGD","LU1914381329.SGD","LU2237443895.HKD","LU2458330169.SGD","SG9999014542.SGD","IE00B3S45H60.SGD","LU0127658192.USD","LU0079474960.USD","LU1366333091.USD","IE00BWXC8680.SGD","LU1642822529.SGD","LU2063271972.USD","IE00BJJMRY28.SGD","LU2168563687.JPY","LU1868836591.USD","LU1868836914.USD","LU2213496289.HKD","IE00BKVL7J92.USD","LU0795875169.SGD","LU0158827948.USD","LU0061475181.USD","LU1917777945.USD","LU0170899867.USD","LU0072462426.USD","LU1803068979.SGD","LU2750360997.AUD","BK4534","LU0069063385.USD","BK4097","LU1582986433.USD","LU2023250330.USD","IE00BJJMRX11.SGD","LU2237438978.USD","IE000YTNTUN2.SGD","LU2357305700.SGD","LU0882574139.USD","LU2347655156.SGD","LU0316494557.USD","LU0553294199.USD","LU0210533765.USD","LU1720051108.HKD","SG9999001424.SGD","LU0323591593.USD","LU1267930730.SGD","LU0444971666.USD","LU1815333072.USD","SG9999014567.USD","LU2602419157.SGD","LU1046421795.USD","IE00BJTD4N35.SGD","LU2896262040.SGD","LU0077335932.USD","LU2111349929.HKD","BK4571","LU0661504455.SGD","LU1989771016.USD","LU2592432038.USD","LU0345769128.USD","LU2756315664.SGD","LU0234572021.USD","LU0158827781.USD","LU0820561909.HKD","LU2065169927.USD","LU0719512351.SGD","IE00BJTD4V19.USD","LU1280957306.USD","LU1242518931.SGD","SG9999018865.SGD","LU1037948541.HKD","LU0096364046.USD","LU2065170008.USD","LU1291159041.SGD","LU0965509283.SGD","LU1935042215.USD","IE00B7KXQ091.USD","IE00B4JS1V06.HKD","LU0868494708.USD","LU0957808578.USD","IE000ITXATA3.USD","LU0314106906.USD","BK4170","BK4512","IE00BK4W5L77.USD","LU2087621335.USD","LU0256863811.USD","LU2271345857.HKD","BK4573","IE00BLSP4452.SGD","LU2125154778.USD","LU1582986359.USD","LU2361044949.HKD","IE0009356076.USD","LU0456855351.SGD","SG9999015341.SGD","IE00BJLML261.HKD","LU1496350502.SGD","SG9999015358.SGD","BK4559","LU2471134523.USD","LU0943347566.SGD","LU0689472784.USD","LU1989764748.USD","LU0912757837.SGD","LU1791710582.SGD","IE00B775H168.HKD","LU2247934214.USD","LU1066053197.SGD","LU0964807845.USD","BK4585","LU0308772762.SGD","LU1551013342.USD","LU2543165471.USD","LU2092627202.USD","LU1261432733.SGD","LU1852331112.SGD","BK4592","LU1934455194.USD","LU1815336760.USD","LU0788109477.HKD","LU1935042991.SGD","IE000W1ABFV2.USD","LU0795875086.SGD","LU0965509010.AUD","LU0642271901.SGD","BK4566","LU0210528500.USD","LU0683600562.USD","SG9999015986.USD","LU2168564149.EUR","LU1732800096.USD","LU1791710400.SGD","LU1868837300.USD","LU1571399168.USD","LU1244550577.SGD","LU0265550359.USD","LU0708995401.HKD","SG9999018857.SGD","LU1496350171.SGD","LU1934455863.HKD","LU0251132253.USD","LU2361044865.SGD","BK4579","IE00B1XK9C88.USD","LU2133065610.SGD","IE00B1BXHZ80.USD","LU0198837287.USD","LU2242650005.HKD","LU1839511570.USD","LU1551013425.SGD","SG9999014906.USD","LU1206713676.USD","IE00BK4W5M84.HKD","LU2430703251.USD","LU2242649171.HKD","LU2028103732.USD","LU2860962120.EUR","LU0672654240.SGD","IE0004445239.USD","IE00BBT3K403.USD","LU2417539215.USD","LU0466842654.USD","LU0942090050.USD","LU0345769631.USD","LU2360032135.SGD","LU1989772840.SGD","LU2458330243.SGD","LU1974910355.USD","LU1582987324.SGD","SG9999014914.USD","LU1206712785.SGD","LU0345768740.USD","LU0057025933.USD","LU2168564065.EUR","LU0823421416.USD","LU0097036916.USD","LU0265550946.USD","LU0354030438.USD","BK4501","LU0726765562.USD","LU2505996509.AUD","IE0004445015.USD","LU0949170772.SGD","LU0868494617.USD","LU0476273544.USD","LU1066051811.HKD","LU2237443549.SGD","LU2286300806.USD","LU1235294995.USD","LU2361045086.USD","SG9999015945.SGD","IE00B19Z9505.USD","BK4527","IE00B3SWFQ91.USD","LU2077746001.SGD","LU1935042488.USD","LU1366192091.USD","LU0511384066.AUD","LU0889565833.HKD","SG9999014880.SGD","LU0053666078.USD","LU0061474960.USD","IE00BZ1G4Q59.USD","LU0289961442.SGD","LU1242518857.USD","LU2089284900.SGD","BK4588","LU2108987350.USD","LU2125154935.USD","LU2505996681.GBP","IE00B4YYXB79.USD","LU1066051498.USD","LU1084165304.USD","LU0314104364.USD","LU0820561818.USD","HK0000306685.HKD","IE000KEQY171.SGD","AAPL","LU1934455277.USD","LU2265009873.SGD","LU0823434583.USD","LU0267386448.USD","LU2360106780.USD","IE00B5949003.HKD","LU0820562030.AUD","LU2054465674.USD","IE00BN29S564.USD","BK4576","LU1037948897.HKD","LU1989764664.SGD","BK4574","LU2191332357.HKD","LU1732799900.SGD","SG9999015952.SGD","LU0957791311.USD","LU2471134879.HKD","LU0149725797.USD","LU0256863902.USD","IE00BN8TJ469.HKD","LU1548497426.USD","LU2746668461.USD","LU0011850046.USD","SG9999002232.USD","LU2237443382.USD","LU1316542783.SGD","LU0215105999.USD","LU0949170426.SGD","LU2430703178.SGD","LU1674673428.USD","SG9999002224.SGD","LU0210536198.USD","LU1720051017.SGD","LU2023251221.USD","LU0823434740.USD","LU0965508806.USD","LU2471134796.USD","LU0689626769.HKD","LU0348723411.USD","LU0784385840.USD","IE00BLSP4239.USD","LU0545039389.USD","LU1145028129.USD","BK4581","IE00B775SV38.USD","LU0345770993.USD","LU2750360641.GBP","BK4515","LU2552382058.USD","SG9999014559.SGD","LU0080751232.USD","LU1003077747.HKD","LU0979878070.USD","LU0048584097.USD","LU1301847155.USD","LU2236285917.USD","BK4575","LU0494093205.USD","LU1119994496.HKD","IE00BFSS7M15.SGD","LU1232071149.USD","LU2097344357.USD","LU0353189680.USD","LU2168564495.EUR","BK4532","LU2168564222.USD","LU2092937148.SGD","BK4598","BK4554","LU2083900584.USD","LU0417517546.SGD","LU0784383803.USD","LU0965509101.SGD","LU2237443622.USD","IE00BSNM7G36.USD","HK0000306701.USD","LU0124676726.USD","LU0724617625.USD","BK4550","LU0289739343.SGD","LU2420271590.USD","LU0109392836.USD","LU2089283258.USD","LU2746668974.SGD","IE0004086264.USD","LU1989772923.USD","LU0154236417.USD","LU2023250504.SGD","LU1935043536.SGD","LU2552382215.SGD","SG9999000418.SGD","LU1035775433.USD","LU1814569148.SGD","SGXZ31699556.SGD","HK0000320223.HKD","LU2462157665.USD","LU0786609619.USD","IE00BFSS8Q28.SGD","LU0784384876.USD","LU0823421333.USD","LU2087625088.SGD","LU2065171311.SGD","LU1778281490.HKD","LU1718418525.SGD","BK4533","IE00B19Z8W00.USD","LU0096362180.USD","LU1868837136.USD","IE0034235303.USD","LU0444973449.USD","LU0320765059.SGD","LU2237443465.HKD","LU2552382132.HKD","LU1116320901.HKD","LU1244550494.USD","LU2487616109.SGD","LU0861579265.USD","LU1629891620.HKD","IE0004091025.USD","LU0787776722.HKD","LU0738911758.USD","LU2023250843.SGD","LU2097344431.USD","LU1804176565.USD","LU0070217475.USD","LU1244550221.USD","LU0082616367.USD","LU0056508442.USD","IE00BKDWB100.SGD","LU2403377893.USD","LU1127390331.HKD","GB00BDT5M118.USD","LU1582987597.SGD","OS","LU0109391861.USD","LU2381873111.SGD","LU1506573853.SGD","MACW.SI","LU0234570918.USD","LU1935043023.USD","LU1069344957.HKD","LU0985320562.USD","BK4553","IE00B19Z8X17.USD","LU1674673691.USD","SG9999014898.SGD","IE0001KFT4U8.USD"],"gpt_icon":1},{"id":"2590451393","title":"吉利德Anito-cel 神经毒性低，2年多发性骨髓瘤生存率高 | ASH25","url":"https://stock-news.laohu8.com/highlight/detail?id=2590451393","media":"Minhua笔记","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590451393?lang=zh_cn&edition=full","pubTime":"2025-12-08 11:58","pubTimestamp":1765166299,"startTime":"0","endTime":"0","summary":"在ASH 2025年会上，吉利德旗下Kite Pharma公布Anito-cel在iMMagine-1 II期试验中的更新数据，该靶向BCMA的CAR-T疗法在复发/难治性多发性骨髓瘤患者中显示96% ORR、74% sCR/CR率、95% MRD阴性率，中位随访15.9个月，缓解持续。III期iMMagine-3试验正在招募中，该研究将Anito-cel与标准治疗比较，预计2026年获得数据；该药物获FDA快速通道、孤儿药和RMAT资格。ICANS 发生率为 8%，其中 1 例为 3 级；其余均为 2 级或更低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208144817a43ac231&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208144817a43ac231&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0889565916.HKD","IE00B7SZL793.SGD","IE00BKVL7J92.USD","LU1571399168.USD","IE00B19Z4B17.USD","SG9999015945.SGD","BK4588","SG9999015978.USD","IE0002270589.USD","PFS","IE00B19Z3581.USD","CRS","IE00B7SZLL34.SGD","LU0289739699.SGD","ORR","LU0823416689.USD","KOL","LU1430594728.SGD","IE00B19Z3B42.SGD","BK4568","OS","BK4097","IE00B66KJ199.SGD","LU1066051498.USD","LU1674673691.USD","BK4195","LU1839511570.USD","GILD","SG9999015952.SGD","BK4550","CR","BK4139","LU0109394709.USD","BK4109","BK4566","LU1674673428.USD","ASH","BK4578","LU0882574055.USD","SG9999015986.USD","LU0234570918.USD","BK4532","IE00BZ1G4Q59.USD","LU1585245621.USD","IE00B3T34201.USD","BK4585","LU1778281490.HKD","BK4187"],"gpt_icon":0},{"id":"1197163681","title":"OneStream与微软加深战略联盟，推动人工智能在财务办公室的应用与价值","url":"https://stock-news.laohu8.com/highlight/detail?id=1197163681","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197163681?lang=zh_cn&edition=full","pubTime":"2025-11-19 04:06","pubTimestamp":1763496393,"startTime":"0","endTime":"0","summary":"OneStream与微软加深了战略联盟，以加速人工智能在财务办公室的应用和创造价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0545562505.USD","BK4528","BK4525","LU0661504455.SGD","LU0056508442.USD","LU0417517546.SGD","LU1551013342.USD","LU1934455863.HKD","LU0690374615.EUR","LU0096362180.USD","IE00BDCRKT87.USD","BK4538","SGXZ99366536.SGD","GB00BDT5M118.USD","LU0912757837.SGD","LU1814569148.SGD","LU2362540622.SGD","LU0225283273.USD","LU2237443978.SGD","LU2506951875.HKD","LU0882574139.USD","IE00BFSS8Q28.SGD","LU0215105999.USD","LU0528227936.USD","IE00B3S45H60.SGD","LU0456855351.SGD","LU1623119135.USD","LU1852331112.SGD","LU0094547139.USD","LU1989764664.SGD","IE00BQXX3C00.GBP","LU2506952170.USD","IE0034235303.USD","LU0171293334.USD","LU1868837300.USD","BK4612","LU0006306889.USD","LU1196500208.SGD","LU2065171311.SGD","LU0127658192.USD","LU1003077747.HKD","LU0323591593.USD","LU1564329115.USD","LU1037948897.HKD","LU0061474960.USD","LU0795875086.SGD","LU0957808578.USD","LU0314106906.USD","LU2250418816.HKD","LU1670628061.USD","LU1791710400.SGD","LU1221951046.USD","LU1868836757.USD","SG9999014567.USD","LU2404859667.USD","IE00BWXC8680.SGD","LU0210528500.USD","LU0265550946.USD","LU0342679015.USD","LU0302445910.USD","LU1066053197.SGD","LU1839511570.USD","IE00BJTD4N35.SGD","OS","LU2461242641.AUD","LU2471134796.USD","LU0965509283.SGD","LU2237957811.SGD","LU2360032135.SGD","LU2420271590.USD","LU0719512351.SGD","LU2237957902.USD","LU0823417653.USD","SG9999015945.SGD","IE00BLSP4452.SGD","LU1720051108.HKD","IE0004445239.USD","LU0472753341.HKD","LU0545039389.USD","LU1564329461.SGD","LU1674673691.USD","LU2487616109.SGD","LU1316542783.SGD","LU0312595415.SGD","BK4566","IE00B19Z8W00.USD","LU1923622614.USD","LU1188199696.SGD","LU2347655156.SGD","LU0965508806.USD","LU1582986359.USD","LU0238689110.USD","IE00BN8TJ469.HKD","LU1228905037.USD","LU1236620750.USD","LU1935042991.SGD","LU1323610961.USD","LU2023251221.USD","LU0353189680.USD","LU1989764748.USD","LU2471134879.HKD","LU1340139317.AUD","LU0345769631.USD","IE00B7KXQ091.USD","LU0795875169.SGD","LU2552382132.HKD","LU1791710582.SGD","LU2543165471.USD","IE00BBT3K403.USD","LU0097036916.USD","LU1496350171.SGD","LU2191332357.HKD","LU1935043023.USD","SG9999015952.SGD","SG9999014914.USD","LU0109391861.USD","LU2023250330.USD","LU0354030511.USD","LU2089283258.USD","LU2087625088.SGD","LU0949170426.SGD","LU2347655073.USD","LU2413666699.HKD","LU1074936037.SGD","LU1989763005.USD","LU0234572021.USD","LU0289961442.SGD","LU1571399168.USD","LU1935042215.USD","LU1815336760.USD","LU1046421795.USD","LU2097344431.USD","LU0784385170.HKD","LU0061474705.USD","LU2458330243.SGD","BK4567","BK4527","IE00BJLML261.HKD","LU2286300806.USD","BK4516","LU0787776722.HKD","SGXZ51526630.SGD","LU1037948541.HKD","LU0124676726.USD","LU2089284900.SGD","LU0149725797.USD","IE0004445015.USD","LU0738911758.USD","LU0323239441.USD","LU1116320737.USD","LU2430703178.SGD","LU2265009873.SGD","LU2456880835.USD","LU0310800379.SGD","LU1629891620.HKD","LU0511384066.AUD","LU2108987350.USD","LU1815333072.USD","LU2462157665.USD","IE0005OL40V9.USD","IE00BJJMRX11.SGD","LU1232071149.USD","LU2413666426.HKD","IE00B4JS1V06.HKD","IE00BFSS7M15.SGD","LU1280957306.USD","LU0690374961.EUR","LU0354030438.USD","LU2125154935.USD","IE00BKDWB100.SGD","LU2505996509.AUD","LU1868837136.USD","IE00BLSP4239.USD","LU0069063385.USD","LU0960925559.SGD","LU1914381329.SGD","LU0267386448.USD","LU0426417589.USD","LU2087621335.USD","LU2168563687.JPY","LU2211815571.USD","LU2023250504.SGD","LU2275660780.HKD","BK4532","SGXZ31699556.SGD","IE00B3SWFQ91.USD","LU1334329650.SGD","LU1366192091.USD","LU2244417387.USD","LU2237438978.USD","IE0009G5SDU7.USD","LU2491050154.USD","LU1064131342.USD","LU2896262040.SGD","SG9999018865.SGD","SG9999014906.USD","LU0965509010.AUD","LU2097829019.USD","LU1582987324.SGD","LU1564329032.USD","LU0072462426.USD","IE00BSNM7G36.USD","LU2361044949.HKD","LU2602419157.SGD","LU1119994496.HKD","LU0689472784.USD","LU2750360997.AUD","LU0057025933.USD","LU1429558221.USD","LU1642822529.SGD","LU1066051225.USD","LU1267930813.SGD","LU0276348264.USD","LU0494093205.USD","LU1548497426.USD","LU2279689827.SGD","BK4503","IE00BMPRXQ63.HKD","GB00B4LPDJ14.GBP","LU0683600562.USD","BK4533","LU1267930730.SGD","LU1721428933.USD","LU2326559502.SGD","IE0034235188.USD","LU0345774391.USD","BK4534","LU1244550577.SGD","LU1582986433.USD","IE00BN29S564.USD","LU0345774631.USD","LU0823417737.USD","LU2133065610.SGD","LU1069347547.HKD","LU2403377893.USD","BK4550","LU0757359368.USD","LU0823421416.USD","LU1084165304.USD","LU0426412945.USD","LU0053666078.USD","LU0011850046.USD","LU2210150020.SGD","LU1228905540.USD","LU1868836914.USD","LU2023250843.SGD","LU2095319765.USD","LU0210533765.USD","LU1366333091.USD","LU2746668461.USD","IE00BKVL7J92.USD","LU0256863811.USD","LU2491049909.HKD","LU0476273544.USD","LU0320765059.SGD","LU1551013425.SGD","IE00BQXX3D17.EUR","LU0353189763.USD","LU0158827781.USD","LU0553294199.USD","LU0345768740.USD","LU2298321311.HKD","LU1670710588.SGD","LU0198837287.USD","IE00BFXG0V08.USD","LU1585245621.USD","LU1301847155.USD","IE00BJTD4V19.USD","BK4579","LU0964807845.USD","BK4548","LU0170899867.USD","LU0345770308.USD","BK4587","LU1803068979.SGD","SG9999002232.USD","LU2764263039.SGD","LU1235294995.USD","LU1935042488.USD","BK4543","LU0949170772.SGD","LU0157215616.USD","LU0792757196.USD","SG9999014575.USD","BK4554","LU0072461881.USD","LU0175139822.USD","LU0965509101.SGD","BK4592","LU0348723411.USD","LU0234570918.USD","IE00BQXX3F31.USD","LU1732800096.USD","LU0557290698.USD","LU0957791311.USD","BK4598","LU0757359954.USD","LU0345768153.USD","SG9999014880.SGD","LU0289960550.SGD","LU2237443465.HKD","SG9999001077.SGD","LU2168564222.USD","BK4577","LU2362541513.USD","LU0106261372.USD","IE00B775H168.HKD","LU2750360641.GBP","LU1127390331.HKD","LU0162691827.USD","LU0323240290.USD","LU0784384876.USD","LU1934455277.USD","LU0784383803.USD","LU1035773651.USD","LU2860962120.EUR","SGXZ81514606.USD","IE00BDRTCR15.USD","LU2433249047.HKD","LU1564329628.SGD","LU0444971666.USD","BK4535","LU0310799852.SGD","LU1261432733.SGD","LU2552382058.USD","LU0724617625.USD","SG9999018857.SGD","LU0211328371.USD","SG9999015986.USD","LU1244550221.USD","IE00B4YYXB79.USD","LU1069344957.HKD","IE00BKPKM429.USD","IE00B5TLWC47.USD","LU0879622024.SGD","LU0820561818.USD","LU2237443549.SGD","LU0889565833.HKD","LU0894486033.HKD","LU2247934214.USD","LU2237443622.USD","IE0004086264.USD","LU1718418525.SGD","SG9999004303.SGD","LU2361045086.USD","LU1236620834.HKD","LU2491050071.SGD","LU2381873111.SGD","LU0823434583.USD","LU0251132253.USD","IE00B775SV38.USD","LU1043141396.HKD","LU0950375773.USD","LU2092937221.SGD","LU2764263203.CNY","LU1221951129.SGD","LU1244550494.USD","LU2720916845.USD","IE000KEQY171.SGD","LU1235295455.SGD","LU1435385759.SGD","MSFT","IE000ITXATA3.USD","LU0048584097.USD","LU0289739343.SGD","IE000W1ABFV2.USD","LU1720051017.SGD","LU2362541273.HKD","LU0266013472.USD","LU1778281490.HKD","LU0265550359.USD","LU1032466523.USD","LU2360108059.USD","LU2361044865.SGD","IE00BYXW3230.USD","LU1803068623.USD","BK4576","LU0347712357.USD","SG9999017495.SGD","LU0107464264.USD","LU2458330169.SGD","LU2505996681.GBP","IE0034235295.USD","LU0868494617.USD","LU0943347566.SGD","LU2168564065.EUR","LU0823434740.USD","SG9999000418.SGD","LU2430703095.HKD","IE00BMPRXR70.SGD","LU0444973449.USD","BK4097","LU1066051498.USD","LU2065171402.SGD","LU2764262908.HKD","BK4585","GB00B4QBRK32.GBP","BK4581","IE00BK4W5L77.USD","LU2168564495.EUR","LU1823568750.SGD","BK4588","LU1712237335.SGD","SG9999015358.SGD","BK4504","LU1674673428.USD","LU0823421333.USD","LU2237443895.HKD","IE00B1XK9C88.USD","LU1153585028.USD","LU1988902786.USD","LU0256863902.USD","LU2111349929.HKD","LU0994945656.USD","LU0640476718.USD","SG9999015978.USD","LU2083900584.USD","LU0211327993.USD","IE00BYQQ9H92.USD","LU0820562030.AUD","LU0726765562.USD","LU0308772762.SGD","LU1059921491.USD","LU0788109477.HKD","LU2756315318.SGD","LU1989772840.SGD","LU1974910355.USD","LU0079474960.USD","LU2357305700.SGD","IE0001KFT4U8.USD","IE00BK4W5M84.HKD","LU0128525929.USD","LU2054465674.USD","LU1633808545.USD","LU0081259029.USD","LU0894485498.HKD","LU0316494557.USD","IE00B1BXHZ80.USD","LU0070217475.USD","LU1116320901.HKD","LU1670711040.USD","LU2097344357.USD","LU2236285917.USD","LU1267930573.SGD","LU0158827948.USD","LU0708994859.HKD","LU0708995401.HKD","LU1043141123.HKD","LU1732799900.SGD","SG9999001424.SGD","IE0004091025.USD","LU0154236417.USD","LU1804176565.USD","LU1989773731.SGD","LU2092937148.SGD","IE00BMPRXN33.USD","LU1181866309.USD","IE0003U64NQ7.SGD","LU0390134368.USD","LU1917777945.USD","LU2125909593.SGD","IE000YTNTUN2.SGD","LU0345769128.USD","IE0009356076.USD","LU0203201768.USD","LU0784385840.USD","LU1032955483.USD","LU2471134952.CNY","LU2463028550.USD","LU2065169927.USD","LU0109392836.USD","SG9999014542.SGD","LU1145028129.USD","LU1670711123.USD","LU0029864427.USD","LU1691799644.USD","LU2552382215.SGD","LU0061475181.USD","LU1430594728.SGD","LU2106854487.HKD","LU1670627923.USD","LU2592432038.USD","LU2506952097.USD","LU0187121727.USD","LU2404859741.USD","LU1121112475.USD","LU1670710661.SGD","LU1582987597.SGD","LU2213496289.HKD","LU2471134523.USD","SG9999002224.SGD","LU2063271972.USD","SG9999015341.SGD","LU1496350502.SGD","LU2264538146.SGD","LU2271345857.HKD","LU0345770993.USD","LU1506573853.SGD","LU1868836591.USD","IE00B19Z9505.USD","LU1989772923.USD","LU1983260115.SGD","IE00BHPRN162.USD","LU2065170008.USD","LU0820561909.HKD","LU2360106780.USD","LU1066051811.HKD","LU1861127337.USD","LU0203202063.USD","LU0210536198.USD","LU0077335932.USD","LU2168564149.EUR","LU2746668974.SGD","LU0096364046.USD","LU1935043536.SGD","LU2041044095.USD","LU2237443382.USD","LU1697837992.HKD","LU0289941410.SGD","LU1934455194.USD","LU2430703251.USD","LU2756315664.SGD","LU2452424414.USD","LU0466842654.USD","LU0889566641.SGD","LU2242650005.HKD","LU2242649171.HKD","IE00B5949003.HKD","LU2125154778.USD","LU2028103732.USD","LU1267930490.SGD","SG9999014559.SGD","IE00BZ1G4Q59.USD","LU0861579265.USD","SG9999014898.SGD","LU0314104364.USD","LU0082616367.USD","LU2417539215.USD","LU2506951958.HKD","LU2092627202.USD","LU0642271901.SGD","LU1035775433.USD","LU0672654240.SGD","LU2125909247.SGD","IE00B19Z8X17.USD","LU0985320562.USD","LU0080751232.USD","IE00BJJMRY28.SGD","LU0095938881.EUR","LU2077746001.SGD","SGXZ23171101.USD","LU0689626769.HKD","LU2210149790.SGD"],"gpt_icon":0},{"id":"1153324361","title":"包括Blackstone和Hg在内的私募股权公司正在研究对OneStream的潜在收购出价","url":"https://stock-news.laohu8.com/highlight/detail?id=1153324361","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153324361?lang=zh_cn&edition=full","pubTime":"2025-11-06 04:48","pubTimestamp":1762375688,"startTime":"0","endTime":"0","summary":"包括Blackstone和Hg在内的私募股权公司正在研究对OneStream的潜在收购出价","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0757428866.USD","LU1815336091.USD","OS","BK4023","BK4097","BL"],"gpt_icon":0},{"id":"2578509299","title":"Os Therapies Incorporated盘中异动 股价大涨6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578509299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578509299?lang=zh_cn&edition=full","pubTime":"2025-10-25 03:57","pubTimestamp":1761335849,"startTime":"0","endTime":"0","summary":"北京时间2025年10月25日03时57分，Os Therapies Incorporated股票出现波动，股价快速上涨6.08%。截至发稿，该股报1.92美元/股，成交量27.5883万股，换手率0.82%，振幅4.97%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.08%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251025035729a6cc92de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251025035729a6cc92de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OSTX","BK4139","OS","BK4097"],"gpt_icon":0},{"id":"2576886096","title":"Os Therapies Incorporated盘中异动 快速下跌5.14%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576886096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576886096?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:13","pubTimestamp":1760710391,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日22时13分，Os Therapies Incorporated股票出现波动，股价急速下挫5.14%。截至发稿，该股报1.76美元/股，成交量33.3201万股，换手率0.99%，振幅6.91%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.05%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017221312a4654783&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017221312a4654783&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RANI","OS","BK4539","BK4097","BK4007","BK4139","ARTV","OSTX"],"gpt_icon":0},{"id":"2575760877","title":"告别繁琐！让AI当你的“生活管家”，是种怎样的体验？","url":"https://stock-news.laohu8.com/highlight/detail?id=2575760877","media":"智东西","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575760877?lang=zh_cn&edition=full","pubTime":"2025-10-16 10:40","pubTimestamp":1760582407,"startTime":"0","endTime":"0","summary":"当下AI圈的热议焦点，往往萦绕于“万亿参数”、“算力突破”等宏大叙事。AI在这里扮演的不是搜索引擎，而是一步到位的服务执行者。在大会现场，AI的演进正经历一场从“控制”到“关怀”的本质蜕变。在陪伴与成长中，AI的角色进化为 “有成长的伙伴”。这也是中国移动董事长杨杰在“AI+”行动中，所提到的“AI+民生保障”的表现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8nUginmB9UB","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["LU0871576103.HKD","LU1008478684.HKD","LU1152091168.USD","LU1634259391.SGD","LU1064131003.USD","BK1506","LU0531971595.HKD","LU1226288253.USD","LU1226287792.SGD","BK4023","BK4528","LU1481107354.HKD","SG9999002463.SGD","LU0880133367.SGD","LU1497734951.SGD","LU1152091754.HKD","LU2148510915.USD","LU1064130708.USD","LU0164865239.USD","BK4551","LU1634259557.SGD","LU0067412154.USD","HK0000252152.HKD","LU1226287529.USD","LU0164880469.USD","LU1951186391.HKD","BK1610","HK0000500386.USD","BK1521","BK4097","LU1226288170.HKD","LU1522347837.USD","LU1497733631.SGD","LU1226287875.USD","80883","AI","HK0000252160.HKD","BK4543","00941","LU0039217434.USD","BK1536","BK4588","OS","BK4585","BK4587","BK1152","LU0149721374.USD","BK1589","LU1497733557.USD"],"gpt_icon":0},{"id":"2574243025","title":"防晒剂龙头创始人逝世","url":"https://stock-news.laohu8.com/highlight/detail?id=2574243025","media":"青眼","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574243025?lang=zh_cn&edition=full","pubTime":"2025-10-11 17:57","pubTimestamp":1760176620,"startTime":"0","endTime":"0","summary":"截至该公告披露日，周久京直接持有科思股份2310万股，占公司股份总额的4.86%，为公司2名实际控制人之一。据悉，周久京逝世前未在科思股份担任任何具体职务。▍截自科思股份公告业绩承压今年上半年营收同比下滑近49%作为“美妆防晒第一股”，科思股份的崛起，却是从合成香料开始。例如，在今年5月的投资者关系文件中，科思股份解释称，2024年业绩下滑的原因，一部分源于防晒剂市场竞争加剧的背景之下，其选择了下调产品价格。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-10-11/doc-inftpmam4915032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0731783394.SGD","LU0772969993.USD","LU1599440770.SGD","AVB","LU0731783048.USD","OMC","BK4588","LU0321505439.SGD","BK4215","LU1509826696.USD","EHT","LU0742537680.HKD","OS","LU1481011671.HKD","LU1481011911.USD","BK4009","LU0321505868.SGD","BK4097","BK4585"],"gpt_icon":0},{"id":"2574154301","title":"德达博妥单抗三阴乳腺癌一线治疗新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2574154301","media":"医药地理","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574154301?lang=zh_cn&edition=full","pubTime":"2025-10-09 17:03","pubTimestamp":1760000637,"startTime":"0","endTime":"0","summary":"德达博妥单抗是一款靶向TROP2的DXd抗体偶联药物，由第一三共研发，并由阿斯利康与第一三共共同开发与商业化。目前，德达博妥单抗已在全球35个以上国家和地区获批，用于治疗经既往内分泌治疗及化疗后、不可切除或转移性HR阳性、HER2阴性乳腺癌患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009171758a6b1b702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009171758a6b1b702&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2417539215.USD","BK4195","BK4007","AZN","LU1829250122.USD","LU0320765992.SGD","OS","BK4211","BK4568","LU2456880835.USD","BK4097","BK4585","BK4588","LU0889565916.HKD","LU2236285917.USD","PFS","LU2462157665.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2573939896","title":"第一三共公布TROPION-Breast02 Ⅲ期研究积极的主要结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2573939896","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573939896?lang=zh_cn&edition=full","pubTime":"2025-10-07 12:19","pubTimestamp":1759810770,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4080","BK4097","ADC","BK4211","BK4231","OS","PFS","BK4195"],"gpt_icon":0},{"id":"2570950855","title":"曝一加氧OS 12 - 15系统存严重漏洞，10月中旬修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2570950855","media":"IT之家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570950855?lang=zh_cn&edition=full","pubTime":"2025-09-26 21:44","pubTimestamp":1758894249,"startTime":"0","endTime":"0","summary":"IT之家 9 月 26 日消息，安全公司 Rapid7 今天上周发布文章，透露一加氧 OS12-15 系统存在严重安全漏洞，可在未经授权的情况下读取 / 发送短信。目前该漏洞已在一加 8T和一加 10 Pro系统中复现，其他型号也有不同程度的影响。不过氧 OS 11 并没有类似的问题，但 Rapid 7 在 2025 年 5 月就报告了这个漏洞并做多次跟进，一加目前已经承认了问题并提出解决方案，承诺将于 10 月中旬起陆续推送安全补丁，彻底封堵上述漏洞。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8myHIZUdfF5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["OS"],"gpt_icon":0},{"id":"2568239777","title":"Os Therapies Incorporated盘中异动 早盘急速跳水6.67%报2.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568239777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568239777?lang=zh_cn&edition=full","pubTime":"2025-09-18 21:55","pubTimestamp":1758203735,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日21时55分，Os Therapies Incorporated股票出现波动，股价急速下挫6.67%。截至发稿，该股报2.05美元/股，成交量7.2274万股，换手率0.23%，振幅3.64%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.68%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918215535a4cddfc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918215535a4cddfc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4097","BK4139","OSTX"],"gpt_icon":0},{"id":"2566665256","title":"医保基金监管细则公开征求意见发布；第一三共新生产大楼开工","url":"https://stock-news.laohu8.com/highlight/detail?id=2566665256","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566665256?lang=zh_cn&edition=full","pubTime":"2025-09-09 10:05","pubTimestamp":1757383554,"startTime":"0","endTime":"0","summary":"政策动向《中药生产监督管理专门规定》发布9月8日，国家药监局公布《中药生产监督管理专门规定》（以下简称《规定》），自2026年3月1日起施行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509093508530127.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509093508530127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4097","BK4231","ADC","02257","OS","BK1161","BK4080"],"gpt_icon":0},{"id":"2565680637","title":"打败“药王”后康方出海数据屡发股价屡跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2565680637","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565680637?lang=zh_cn&edition=full","pubTime":"2025-09-08 22:05","pubTimestamp":1757340300,"startTime":"0","endTime":"0","summary":"康方生物的依沃西单抗作为全球首创PD-1/VEGF双靶点抗肿瘤药，曾在国内试验中击败“药王”K药。9月7日，康方生物发布依沃西单抗海外临床试验最新数据，显示生存获益较此前5月分析结果有明显改善趋势，但9月8日，康方生物股价下跌7.89%，其海外合作伙伴Summit开盘跌17.5%。FDA前临床高级审评员认为，此次发布的数据仍不能说明已达到总生存期（OS）的显著获益，而OS数据是肿瘤药物能否获批上市的最重要指标。9月7日的数据是对5月底全球多中心三期试验结果的更新，5月底数据显示OS数据虽呈改善趋势，但未达到试验标准中的统计学显著性获益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908222513a4bb8f74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908222513a4bb8f74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","BK4097","OS"],"gpt_icon":0},{"id":"2565850646","title":"百济神州今日宣布RATIONALE-315研究的最终分析结果和RATIONALE-303研究的长期随访数据显示百泽安（替","url":"https://stock-news.laohu8.com/highlight/detail?id=2565850646","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565850646?lang=zh_cn&edition=full","pubTime":"2025-09-08 19:38","pubTimestamp":1757331495,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1303224171.USD","BK4585","ONC","BK1500","BK4097","BK1583","BK1588","06160","BK4139","LU1969619763.USD","OS","BK0239","BK1161","LU0307460666.USD","BK4526","LU1770034418.SGD","LU1251922891.USD","LU2328871848.SGD","688235","LU0588546209.SGD","LU1719994722.HKD"],"gpt_icon":0},{"id":"2565794405","title":"中信里昂：维持康方生物(09926.HK)目标价177港元 评级“跑赢大市“","url":"https://stock-news.laohu8.com/highlight/detail?id=2565794405","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565794405?lang=zh_cn&edition=full","pubTime":"2025-09-08 10:00","pubTimestamp":1757296826,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0540923850.HKD","LU0417516738.SGD","LU2778985437.USD","BK4097","09926","OS","BK4007","LU0348767384.USD","LU0348784397.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","IE00BPRC5H50.USD","BK4139","LU0348827113.USD","LU2476274308.USD","BK4134","BK4539","LENZ","BK1574","LU0561508036.HKD","LU0348783233.USD","LU0634319403.HKD","LU0348825331.USD","LU0417516571.SGD","LU0348735423.USD","III","LU0348766576.USD","LU2488822045.USD","BK1161","LU1720050803.USD","LU1794554557.SGD","LU2476274720.SGD","LU0417516902.SGD"],"gpt_icon":0},{"id":"2565198595","title":"1400亿广东明星药企，筹资35亿出征全球","url":"https://stock-news.laohu8.com/highlight/detail?id=2565198595","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565198595?lang=zh_cn&edition=full","pubTime":"2025-09-06 17:31","pubTimestamp":1757151073,"startTime":"0","endTime":"0","summary":"一支广东中山的创新药团队，再次募得巨资。9月4日，康方生物公告，已完成新一轮配售，发行新股2355万股，募资近35亿港元。董事会主席、总裁兼CEO夏瑜，及其同事李百勇，也同期出让部分股权。这两年，康方已有三轮募资，筹集金额超过65亿港元。夏瑜领导的这家明星药企，正面临商业爬坡期与临床高投入期的双重压力，其已有7款自研产品上市，加之庞大的后期管线在快速推进，需要持续的资金支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509063506758557.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509063506758557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0348766576.USD","LU0348767384.USD","LU2488822045.USD","LU0417516571.SGD","LU1989771016.USD","LU0965509283.SGD","LU1934455277.USD","LU0070302665.USD","LU1934455863.HKD","LU1917777945.USD","LU1037948897.HKD","LU1983299246.USD","LU2112291526.USD","BK4550","LU1057294990.SGD","BK4516","LU0965509010.AUD","LU1974910355.USD","OS","SG9999014559.SGD","SG9999014567.USD","LU2476274720.SGD","LU0540923850.HKD","LU0348825331.USD","LU1037948541.HKD","LU1794554557.SGD","LU2778985437.USD","LU1035773651.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","LU1989772840.SGD","LU0211331839.USD","SG9999015358.SGD","SG9999014575.USD","LU0965508806.USD","LU0058720904.USD","MRK","LU1941712264.USD","SG9999002224.SGD","LU0320765646.SGD","BK4007","LU0234572021.USD","SG9999014542.SGD","IE0002141913.USD","LU2361044949.HKD","09926","LU1069347547.HKD","LU1066051811.HKD","IE00BPRC5H50.USD","LU2023250504.SGD"],"gpt_icon":0},{"id":"2562701704","title":"“大牛股”康方生物，核心产品大卖亏损却扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=2562701704","media":"时代财经APP","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562701704?lang=zh_cn&edition=full","pubTime":"2025-08-28 12:12","pubTimestamp":1756354374,"startTime":"0","endTime":"0","summary":"财报数据显示，今年上半年，康方生物总收入为14.12亿元，同比增长37.75%。在商业授权收入方面，康方生物在今年上半年已收到990万元。不过，截至今年上半年，康方生物仍处于亏损状态，且亏损金额进一步扩大，为5.88亿元，这一数字在去年同期为亏损2.49亿元。投资者更为关注的是，康方生物核心产品的研发和商业化销售情况，尤其是依沃西在全球市场头对头试验进展。上述相关负责人表示，今年上半年，康方生物在中国市场医院覆盖进一步深化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828125215a4a424fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828125215a4a424fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1116320737.USD","LU0203347892.USD","LU1023059063.AUD","LU1037948541.HKD","LU1061106388.HKD","LU1989772923.USD","BK4007","SGXZ57979304.SGD","BK4516","LU1974910355.USD","LU0208291251.USD","LU1035773651.USD","LU1066051225.USD","LU1057294990.SGD","SG9999013999.USD","LU0070302665.USD","LU2487616109.SGD","LU2023250843.SGD","LU0211331839.USD","LU2106854487.HKD","IE00BBT3K403.USD","BK4585","BK4107","MRK","SG9999015341.SGD","IE00BJT1NW94.SGD","LU1934455277.USD","LU0058720904.USD","LU1093756325.SGD","LU2468319806.SGD","LU0106261372.USD","LU1585245621.USD","LU2324357040.USD","SG9999014575.USD","OS","SG9999001176.SGD","SG9999014542.SGD","LU1941712264.USD","LU1934455863.HKD","IE000M9KFDE8.USD","L","LU0965509010.AUD","BK4008","IE00BSNM7G36.USD","ALK","LU2023250504.SGD","IE00BN8TJ469.HKD","LU1929549753.HKD","BK4534","SG9999001440.SGD"],"gpt_icon":0},{"id":"2562709883","title":"康方生物Key data readouts for AK112 to validate","url":"https://stock-news.laohu8.com/highlight/detail?id=2562709883","media":"招银国际","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562709883?lang=zh_cn&edition=full","pubTime":"2025-08-28 11:21","pubTimestamp":1756351315,"startTime":"0","endTime":"0","summary":"AK104和AK112两款药物分别因纳入国家医保目录，在二线及以上的宫颈癌和EGFR突变非小细胞肺癌治疗中推动了销售增长。预计到2026年，随着更多适应症进入NRDL，如一线胃癌、一线宫颈癌和PD-L1阳性非小细胞肺癌等，将进一步加速产品销售。同时，公司计划启动一项针对IO耐药二线肝细胞癌的全球II期注册试验，并探索AK104与AK112联合用药的可能性。此外，Akeso还正在开发HER3ADC和Trop2/Nectin4ADC等早期项目，进一步丰富其研发管线。与此同时，AK104的国际合作潜力也被看好。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828114047a4a40388&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828114047a4a40388&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PFS","BK4097","BK4211","BK4195","OS"],"gpt_icon":1},{"id":"2562775214","title":"欧盟委员会批准百泽安®用于非小细胞肺癌患者新辅助/辅助治疗 最新数据将在2025年世界肺癌大会上公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2562775214","media":"美通社","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562775214?lang=zh_cn&edition=full","pubTime":"2025-08-27 19:20","pubTimestamp":1756293600,"startTime":"0","endTime":"0","summary":"EC的此项批准是基于3期RATIONALE-315研究结果。具体数据将于2025年9月6日至9日在西班牙巴塞罗那举行的国际肺癌研究协会2025年世界肺癌大会上作为最新突破摘要[1]公布。关于RATIONALE-315 RATIONALE-315是一项随机（1:1）、双盲、安慰剂对照、多中心、3期临床试验，评估了百泽安用于453例既往未经治疗、可切除的II期或IIIA期非小细胞肺癌成人患者新辅助/辅助治疗的效果。百泽安已在47个国家和地区获批，全球超过170万例患者接受了治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4760157_ZH60157_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1161","LU0106831901.USD","EC","LU0588546209.SGD","688235","BK0239","BK4526","BK4585","BK4139","LU1969619763.USD","BK1588","DFS","LU2360107671.USD","LU0307460666.USD","LU1861220207.SGD","BK4201","BK4097","TRAE","BK1500","ONC","LU1861217088.USD","OS","BK1583","06160","LU1791807156.HKD","LU1668664300.SGD","BK4588","LU2328871848.SGD","BK4166"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onestream.com","stockEarnings":[{"period":"1week","weight":-0.0338},{"period":"1month","weight":-0.1984},{"period":"3month","weight":-0.0648},{"period":"6month","weight":-0.3551},{"period":"1year","weight":-0.427},{"period":"ytd","weight":-0.378}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"OneStream, Inc.于2021年10月15日在特拉华州注册成立。OneStream提供了一个统一的、支持人工智能和可扩展的软件平台——数字金融云，使首席财务官办公室现代化并增加其战略影响力。他们的平台将核心财务和更广泛的运营数据和流程统一在一个平台内，其解决方案保持了公司财务报告标准的完整性，同时为业务用户提供了重要的运营见解。通过专门为财务构建的嵌入式应用人工智能和机器学习技术，他们的平台自动化和简化了工作流程，加速了分析并提高了预测准确性，使首席财务官办公室能够报告、预测和指导业务绩效。","exchange":"NASDAQ","name":"OneStream, Inc.","nameEN":"OneStream, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"OneStream, Inc.(OS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供OneStream, Inc.(OS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"OneStream, Inc.,OS,OneStream, Inc.股票,OneStream, Inc.股票老虎,OneStream, Inc.股票老虎国际,OneStream, Inc.行情,OneStream, Inc.股票行情,OneStream, Inc.股价,OneStream, Inc.股市,OneStream, Inc.股票价格,OneStream, Inc.股票交易,OneStream, Inc.股票购买,OneStream, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"OneStream, Inc.(OS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供OneStream, Inc.(OS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况